Cargando…

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

OBJECTIVE: Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a bioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edén, Arvid, Marcotte, Thomas D., Heaton, Robert K., Nilsson, Staffan, Zetterberg, Henrik, Fuchs, Dietmar, Franklin, Donald, Price, Richard W., Grant, Igor, Letendre, Scott L., Gisslén, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905676/ https://www.ncbi.nlm.nih.gov/pubmed/27295036 http://dx.doi.org/10.1371/journal.pone.0157160

Ejemplares similares

Blood–brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV
por: Anesten, Birgitta, et al.
Publicado: (2016)

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
por: Gisslén, Magnus, et al.
Publicado: (2011)

Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023)

Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis
por: Edén, Arvid, et al.
Publicado: (2021)

Blood biomarkers for HIV infection with focus on neurologic complications—A review
por: Hagberg, Lars, et al.
Publicado: (2022)

Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection
por: Ahlgren, Erika, et al.
Publicado: (2016)

Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes
por: Abdulle, Sahra, et al.
Publicado: (2008)

Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy
por: Gisslén, Magnus, et al.
Publicado: (2012)

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2021)

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2022)

Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
por: Jessen Krut, Jan, et al.
Publicado: (2014)

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
por: Gisslén, Magnus, et al.
Publicado: (2015)

Corrigendum to: “Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study” [EBioMedicine 3 (216) 135–140]
por: Gisslén, Magnus, et al.
Publicado: (2016)

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance
por: Hagberg, Lars, et al.
Publicado: (2020)

Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up
por: Kanberg, Nelly, et al.
Publicado: (2021)

Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
por: Edén, Arvid, et al.
Publicado: (2022)

Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV
por: Saloner, Rowan, et al.
Publicado: (2022)

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
por: Yilmaz, Aylin, et al.
Publicado: (2019)

Serum neopterin levels in relation to mild and severe COVID-19
por: Robertson, Josefina, et al.
Publicado: (2020)

Higher plasma drug levels in elderly people living with HIV treated with darunavir
por: Tyrberg, Erika, et al.
Publicado: (2021)

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
por: Sörstedt, Erik, et al.
Publicado: (2016)

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study
por: Yilmaz, Aylin, et al.
Publicado: (2006)

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
por: Rogers, Jeffrey M., et al.
Publicado: (2023)

Neurocognitive functioning in acute or early HIV infection
por: Moore, David J., et al.
Publicado: (2010)

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression
por: Gisslen, Magnus, et al.
Publicado: (2021)

CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
por: Gisslén, Magnus, et al.
Publicado: (2018)

Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection
por: Peterson, Julia, et al.
Publicado: (2014)

The effect of vitamin B supplementation on neuronal injury in people living with HIV: a randomized controlled trial
por: Tyrberg, Erika, et al.
Publicado: (2022)

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate
por: Hermansson, Linn, et al.
Publicado: (2019)

Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study
por: Ulfhammer, Gustaf, et al.
Publicado: (2021)

Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients
por: Bocci, Matteo, et al.
Publicado: (2021)

Reduction of the HIV-1 reservoir in resting CD4(+ )T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
por: Lindkvist, Annica, et al.
Publicado: (2009)

Sex difference in circulating soluble form of ACE2 protein in moderate and severe COVID-19 and healthy controls
por: Robertson, Josefina, et al.
Publicado: (2022)

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
por: Hermansson, Linn, et al.
Publicado: (2019)

Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial
por: Thela, Lindokuhle, et al.
Publicado: (2023)

Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
por: Jespersen, Sofie, et al.
Publicado: (2016)

Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model
por: Saloner, Rowan, et al.
Publicado: (2021)

Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning
por: Bharti, Ajay R, et al.
Publicado: (2016)

Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection
por: Price, Richard W., et al.
Publicado: (2013)

Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes
por: Eisengart, Julie B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iki2p2qspg77qsculu7hf34gf8